Log In
Print
BCIQ
Print
Print this Print this
 

AuriPro (formerly OTO-201)

  Manage Alerts
Collapse Summary General Information
Company Otonomy Inc.
DescriptionSustained-release gel formulation of ciprofloxacin
Molecular Target DNA gyrase
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationOtitis media
Indication DetailsIntraoperative treatment of middle ear effusion in pediatric patients requiring tympanostomy tube placement surgery; Treat acute otitis media (AOM); Treat otitis media in pediatric patients undergoing tympanostomy tube replacement surgery; Treat recurrent or persistent otitis media
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today